Project description
A simple device worn on the forehead continuously monitors objective biomarkers of brain function
Early diagnosis of brain-related pathologies and continuous monitoring of brain function would revolutionise our ability to treat conditions including anxiety, sleep disorders, autism, and Alzheimer’s and Parkinson’s diseases. This would enhance the quality of life of patients and their families and relieve healthcare systems of a tremendous burden. The Israeli SME Neurosteer has developed a non-invasive system that is worn on the forehead, providing a unique window to the brain’s function that can be used in clinical and home settings. It enables automatic interpretation of objective biomarkers and real-time feedback and can be monitored remotely. The EU-funded NS System project is fine-tuning the technology behind its platform and preparing to take it to market.
Objective
Neurological disorders, ranging from epilepsy, autism, dementias, Alzheimer’s and Parkinson’s diseases affect 1B people worldwide. Currently, Europe has the greatest percentage of population aged 65 or over (25%) and these numbers are expected to drastically grow (3% per year) increasing the population affected by brain disorders. Many neurological disorders can be prevented and treated using brain monitoring systems that assume a crucial role in the diagnosis of these diseases. Current monitoring technologies include sub-hairline electroencephalography (EEG)-based systems, EEG caps with gel electrodes and imaging techniques such as functional Magnetic Resonance Imaging (fMRI). However, these solutions are not portable presenting uncomfortable and poor measurement accuracy (EEG cap), no real-time extraction of brain parameters and dynamics (sub-hairline EEG systems) and expensive solutions (imaging techniques).
Neurosteer has developed NS System, a forehead-wearable real-time and continuous brain monitoring system with a dedicated software component that interprets brain signals producing biomarkers for level of anesthesia, cognitive load, epilepsy and disorders of consciousness. Doctors and caregivers have direct access to the recorded biomarkers through a customized cloud application and they can modify the therapy if needed, based on the recordings. NS system guarantees effective brain monitoring, real-time extraction of brain biomarkers and brain dynamics prediction with an extremely affordable price for the customers. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, Neurosteer will optimize hardware and software components of the NS system to extract also predictive biomarkers of epileptic and sleeping activities. Clinical trials will then be initiated to obtain the CE mark as a medical device.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology electrical engineering, electronic engineering, information engineering electronic engineering signal processing
- medical and health sciences basic medicine neurology
- natural sciences computer and information sciences artificial intelligence machine learning
- medical and health sciences clinical medicine clinical neurology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
46725 HERZLIYYA
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.